Aker Biomarine Asa · OSL:AKBM
Aker Biomarine Asa — Shareholder Meeting (April 2010)
34 slides from Aker Biomarine Asa's shareholder meeting presentation, Apr 8, 2010
Slide 1: Annual general meeting
Annual general meeting Oslo, April 8 2010 Th preferred The f d partner t part of Aker
Slide 2: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 3: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 4: Aker BioMarine overview
Aker BioMarine overview Krill Other Tonalin® / CLA royalty Pharmaceutical and Omega‐3 Omega 3 Concentrate Holding functions Harvesting, production, documentation and sales & marketing NOK 125m NOK 20m Th preferred The f d partner t part of Aker © Aker |
Slide 5: Highlights 2009
Highlights 2009 International break through in the US • Aker BioMarine signed an exclusive supply agreement of Superba™ Krill with a market leader in US. Superba™ Krill to be used in joint and eye health products • Aker BioMarine signed a long‐term global supply agreement for the use of Superba™
Slide 6: Key performance indicators
Key performance indicators 2007 – 2009* Revenues Operating cash flow Superba™ Krill sold QrillTM feed sold NOKm NOKm MT MT 160 0 60 8 000 140 7 000 -50 50 120 6 000 -100 40 100 5 000 80 -150 30 4 000 60 3 000 -200 20 40 2 000 -250 10 20 1 000 0 -300 0 0 2007 2008 2009 2007 2008 2009 2007 2008 2009 2
Slide 7: Income statement 2009
Aker BioMarine consolidated statements Income statement 2009 Comments NOK million 2009 2008 Revenue growth of NOK 60m Operating revenues 145 85 • Superba™ Krill NOK 50m (0) Cost of goods sold and changes in inventories -63 -9 Salaries and payroll costs -58 -59 • Qrill™ NOK 59m (53) Other operating
Slide 8: Balance sheet
Aker BioMarine consolidated statements Balance sheet NOK million 2009 2008 Comments ASSETS 12 prosent equity ratio Property, plant and equipment Intangible assets 492 496 478 524 Cash and cash equivalents of NOK 8m Interest-bearing long-term receivables 0 563 Total non-current assets 989 1 565
Slide 9: 2.2. Proposed resolution
2.2. Proposed resolution “The general meeting resolved to approve the annual accounts for 2009 for Aker BioMarine ASA, the group consolidated accounts and the annual report” Th preferred The f d partner t part of Aker © Aker |
Slide 10: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 11: 2.3 Proposed resolution
2.3 Proposed resolution “The nomination committee proposes the following remuneration for Board members for the period 2009‐2010: Board Chairman: NOK 300,000 Board members: NOK 200,000” , Th preferred The f d partner t part of Aker © Aker |
Slide 12: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 13: 2.4 Proposed resolution
2.4 Proposed resolution “The following remuneration for nomination committee members i proposed is d ffor the h period i d 2009‐2010: 2009 2010 Chairman and members: NOK 30,000” Th preferred The f d partner t part of Aker © Aker |
Slide 14: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 15: 2.5 Proposed resolution
2.5 Proposed resolution “The The general meeting approved the auditor’s auditor s fees of NOK 721 475 for the audit of Aker BioMarine ASA in 2009” Th preferred The f d partner t part of Aker © Aker |
Slide 16: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 17: 2.6 Proposed resolution
2.6 Proposed resolution “The general meeting resolved to endorse the Board of Directors’ statement included in note 30 to the consolidated Directors accounts on page 42 of the annual report, and to approve the remuneration proposed by the Board” Th preferred The f d partner t part of Aker © Aker |
Slide 18: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 19: 2.7 Proposed resolution
2.7 Proposed resolution “The The nomination committee proposes no changes to the board of directors” Pursuant to the company’s p y articles of association,, the Board is to comprise from three to nine Board members. The Board now comprises of five Board members. None of these are up for election thi
Slide 20: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 21: 2.8 Proposed resolution
2.8 Proposed resolution “The nomination committee proposes no changes to the nomination committee” No members of the nomination committee are up for election this year Th preferred The f d partner t part of Aker © Aker |
Slide 22: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 23: 2.9 Proposed resolution
2.9 Proposed resolution “Until the annual general meeting in 2011 the Board of Directors may resolve to call an extraordinary shareholders’ meeting by issuance of a notice of general meeting to the shareholders within two weeks prior to the meeting” Th preferred The f d partner t part of Aker © Aker
Slide 24: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 25: 3. Proposed resolution
3. Proposed resolution ”Vedtektenes § 7 endret til å lyde: Selskapets firma tegnes av styrets leder alene eller to styremedlemmer i fellesskap hvorav minst en må være aksjonærvalgt”* j g “Section 9 of the Articles of Association is amended as follows: Notice of the General Meeting shall be made by w
Slide 26: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 27: 4. Proposed resolution
4. Proposed resolution “The annual general meeting approves the agreement with Aker ASA regarding the sale of receivables and the settlement of debt positions, and authorizes the Board of Directors to make minor changes to the agreement” Th preferred The f d partner t part of Aker © Aker |
Slide 28: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 29: 5. Proposed resolution
5. Proposed resolution The annual general meeting approves the agreement regarding a guarantee from Aker ASA with the appurtenant mortgage agreements, and authorizes the Board of Directors to make minor changes to the agreement.” Th preferred The f d partner t part of Aker © Aker |
Slide 30: Agenda
Agenda 1. Opening of the annual general meeting and election of person to co‐sign meeting minutes along with meeting chair 2. Ordinaryy items 2.1 Presentation of business activities 2.2 Approval of the 2009 annual accounts of Aker BioMarine ASA and consolidated accounts and the Board of Directors’ R
Slide 31: 6. Proposed resolution (i)
6. Proposed resolution (i) The Company’s share capital shall be increased by no less than NOK 586,000,000 and no more than NOK 638,000,000 through share issue of no less than 586,000,000 and no more than 638,000,000 new shares, each with the nominal value of NOK 1. The subscription rate per share wi
Slide 32: 6. Proposed resolution (ii)
6. Proposed resolution (ii) 4. Allocation of shares subscribed in the share issue is made by the Company’s Board of Directors. The following allocation principles shall apply (with the modifications for Aker Seafoods Holding AS as described in section 2 above): (i) Shares will be allotted to subscri
Slide 33: 6. Proposed resolution (iii)
6. Proposed resolution (iii) 6. The subscription period will commence on 15 April 2010 and expire on 29 April at 17:30h (Oslo time). In the event that the prospectus has not been approved before the intended commencement of the subscription period, the subscription period will commence on the fourth
Slide 34: Disclaimer
Disclaimer This Document includes and is based, inter alia, on forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. These statements and this Document are based on current expectations expectations, estimates and projecti